Cutaneous Adverse Effects Common With Enfortumab Vedotin for Urothelial Cancer
Researchers described dermatologic events associated with the use of enfortumab vedotin in treatment of locally advanced/metastatic urothelial cancer.
Side-Effect Management
PRE Training Improved Self-Efficacy, Promoted Symptom Management in Patients With Lung Cancer
Undergoing progressive relaxation exercise training improved management of distress, physical symptoms, and psychological symptoms in patients receiving chemotherapy for lung cancer.
Survey Reveals Oncologists’ Preferences Regarding Scalp Cooling Therapy
Researchers identified patterns around usage of scalp cooling therapy to reduce the risk of chemotherapy-induced alopecia in patients.
Many Cancer Patients Lack Immunity for Measles, Mumps
Overall seroprevalence of measles and mumps antibodies 0.75 and 0.62 for ambulatory cancer patients.
Patients With Comorbidities Are More Likely to Undergo Colorectal Cancer Screening
Patients without comorbidities were less likely to undergo screening for colorectal cancer than patients with comorbidities.
Olanzapine Substitution Effective in Triple Therapy for Carboplatin-Induced CINV
Researchers explored the effectiveness of olanzapine with granisetron and dexamethasone in patients with thoracic malignancies.
Acupuncture Techniques Reduced Chronic Musculoskeletal Pain in Cancer Survivors
A randomized trial sought to determine the effectiveness of electroacupuncture and auricular acupuncture in managing musculoskeletal pain in cancer survivors.
Anticoagulants Not Effective in Managing Recurrent PE After Subsegmental Pulmonary Embolism
Retrospective study sought to determine incidence of pulmonary embolism after a diagnosis of subsegmental pulmonary embolism in patients with cancer.
New Guidelines Help Decision Making for the Prevention, Management of Venous Thromboembolism
The American Society of Hematology released guidelines for preventing and managing venous thromboembolism in patients with cancer.
Risk Factors Associated With Chemotherapy-Induced Peripheral Neuropathy
Researchers identified the risk factors for chemotherapy-induced peripheral neuropathy in cancer patients treated with paclitaxel or oxaliplatin.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...